Jafron Biomedical Co.,Ltd. (SHE:300529)
18.98
+0.19 (1.01%)
At close: Mar 6, 2026
-25.42% (1Y)
| Market Cap | 14.70B -30.0% |
| Revenue (ttm) | 2.04B -22.6% |
| Net Income | 481.79M -40.1% |
| EPS | 0.63 -37.8% |
| Shares Out | 774.36M |
| PE Ratio | 30.15 |
| Forward PE | 26.83 |
| Dividend | 0.80 (4.26%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 3,174,070 |
| Average Volume | 4,577,754 |
| Open | 18.72 |
| Previous Close | 18.79 |
| Day's Range | 18.71 - 19.00 |
| 52-Week Range | 18.70 - 27.21 |
| Beta | 0.43 |
| RSI | 33.90 |
| Earnings Date | Apr 28, 2026 |